Dorsavi Ltd. · ASX:DVL
Dorsavi — Shareholder Meeting (November 2023)
9 slides from Dorsavi's shareholder meeting presentation, Nov 30, 2023
Slide 1: AGM Presentation November 2023
For personal use only AGM Presentation November 2023
Slide 2: Year in review
Year in review For personal use only October 2022 • Announced development of new sensor application in collaboration with Medtronic to assess movement quality of patients with spinal conditions worth A$195,000 April 2022 • Commenced clinical project with the University of Rochester Medical Center wo
Slide 3: FY23 Key Operating Metrics
FY23 Key Operating Metrics For personal use only $1.8m $1.1m $1.0m Sales revenue Annualised recurring revenue New contracts signed ~$538k 86% 22% As at Sept 2023 Gross profit margin Reduction in opex from FY221 (does not include $400k Capital raise Nov 2023) Source: Company financials 1. Defined as
Slide 4: Clear and validated strategy - valuable target markets
Clear and validated strategy - valuable target markets Targeting two key valuable markets with attractive growth propositions For personal use only Workplace Clinical ✓ Selling sensors direct to physical therapists ✓ Contracts with tier one enterprise customers (PT), utilising existing reimbursement
Slide 5: Continuous innovation
Continuous innovation Investments into clinical grade product unlocks exciting growth pathways For personal use only Larger addressable market Reaching more research institutions and corporations who mandate strict data security Superior value proposition Enhancement Enhanced functionality and incre
Slide 6: Lean expense management
Lean expense management Effective cost base reduction leads to a sustainable business model For personal use only Operating expenses (A$m)1 Cost initiatives -22% Workforce optimisation $5.4m ✓ Product enhancements driving greater efficiencies $5.1m $5.0m ✓ Optimised senior management structure ~$4.2
Slide 7: Industry tailwinds supportive of growth
Industry tailwinds supportive of growth dorsaVi is well placed to capitalise on macroeconomic trends For personal use only AI revolution Digital health Workplace Safety dorsaVi’s early use of AI places the Increasing demand for wearable Focus on employee well-being company in a strong position to te
Slide 8: Important information and disclaimer
Important information and disclaimer For personal use only Not financial product advice or offer This presentation does not constitute an offer of securities or investment, legal, taxation or other advice and the presentation does not take into account your investment objectives, financial situation
Slide 9: Contact us
For personal use only Contact us Company Andrew Ronchi Director and CEO T: +61 417 882 267 E: ar@dorsavi.com Investors Dean Dribbin Vesparum Capital T: +61 3 8582 4800 E: dorsavi@vesparum.com Unit 3, 11-13 Milgate Street South Oakleigh, Vic, 3167 www.dorsavi.com